Raymond Cheung
Chartered Actuary · CRO · Board Adviser · Singapore
MAS's Guidelines on Corporate Governance for designated financial holding companies, banks, and insurers incorporated in Singapore — most recently touched by the Notice 106 amendment effective 30 May 2026 — are not a checklist a company secretary files quietly. They reach into remuneration oversight of material risk takers, mandatory documentation of independent directors' dissent, and related-party transaction oversight in ways most insurer boards still treat as compliance rather than governance.
I have sat on the receiving end of a board pack where the corporate governance guideline compliance section was a single slide — a table of provisions with a green tick next to each one. Nobody in the room could tell you, if asked, what the board had actually done that year to earn that tick. That is the failure mode MAS's Guidelines on Corporate Governance for designated financial holding companies, banks, direct insurers, reinsurers and captive insurers incorporated in Singapore are designed to close, and it's a failure mode I still see regularly on insurer boards that treat the Guidelines as a legal filing exercise rather than a description of how the board is actually supposed to work.
This is a live, amended framework — not a 2021 artefact
The Guidelines were substantively revised in 2021 following a public consultation, but they are not static. MAS Notice 106 — which governs the appointment of directors, the chairman, nominating committee members, and key executive persons for insurers, and which reaches every Tier 1 insurer's chief executive, CFO, CRO, appointed actuary and certifying actuary — was itself amended again, with the amendment taking effect on 30 May 2026. Boards that last reviewed their governance framework against the 2021 text and assumed the file was closed are working from a document that has since moved. That matters practically: appointment and fit-and-proper processes that were compliant in 2022 are not automatically compliant today just because nobody flagged a problem.
Remuneration oversight now reaches past the C-suite
The provision I find boards most consistently under-engage with is the extension of remuneration oversight beyond executive officers to Material Risk Takers — employees whose individual actions can materially affect the insurer's risk exposure, who are not necessarily executives and may sit several layers down the organisation chart. The Board Remuneration Committee is expected to actively oversee and monitor the effectiveness of remuneration policy for this group, evaluating outcomes in aggregate to confirm they don't create incentives for excessive risk-taking. Most remuneration committees I have observed spend the bulk of their time on the CEO and the direct reports whose pay packages get board-level scrutiny by habit. Very few can tell you, without going back to management for the answer, who their MRT population actually is this year, or whether that population's incentive structure has been stress-tested against the same risk-taking concerns the Guidelines are aimed at.
“A remuneration committee that can name its five most senior executives' pay but not its Material Risk Takers has satisfied the letter of the old Guidelines and missed the point of the current ones.”
Board minutes are now expected to record disagreement, not just decisions
A second provision that is easy to treat as procedural and hard to actually implement: the Guidelines expect financial institutions to document, in board meeting minutes, the unresolved concerns of independent directors — particularly where those concerns relate to how the company is being run or to a proposed corporate action. This is a deliberate departure from the convention of minutes that record only what was approved. It exists because a board's real governance value often shows up in what an independent director objected to and could not get resolved, not in the unanimous votes. I have reviewed board minutes from more than one Singapore financial institution where every recorded vote across a full year was unanimous — not because the board agreed on everything, but because dissent was resolved informally before the meeting or never written down. That pattern is precisely what this provision is meant to surface, and it is precisely the pattern a MAS inspection or a post-incident review will go looking for first.
Related-party oversight is a standing duty, not a transaction-by-transaction check
The Guidelines also place oversight of related-party transactions squarely with the board, not delegated wholesale to management or buried inside an audit committee's annual review. For insurers with related corporations, substantial shareholders, or intra-group service arrangements — common in Singapore's insurance market, where many players sit inside larger regional or global groups — this is not a once-a-year exercise. It is an expectation that the board maintains ongoing visibility into related-party arrangements and can demonstrate, if asked, that those arrangements were assessed on arm's-length terms and in the interest of policyholders and minority shareholders, not just the parent group's convenience.
- Can the remuneration committee name its current Material Risk Taker population and describe how their incentive structure was evaluated in aggregate this year — without asking management to pull the list first?
- Do this year's board minutes show any recorded, unresolved concern from an independent director, or does a full year of unanimous votes suggest disagreement was being resolved off the record?
- Is related-party transaction oversight a standing board agenda item with real documentation, or a once-a-year audit committee memo that gets nodded through?
None of these three gaps require new committees, new headcount, or outside consultants to close. They require a board to stop treating the Guidelines as a compliance artefact from 2021 and start treating them as a live description of how MAS expects the board to actually function this year. The insurers that get this right will have board packs that read as evidence of governance. The ones that don't will have a green tick on a slide and nothing behind it when someone finally asks.
Common Questions
Do MAS's Corporate Governance Guidelines apply to all insurers in Singapore?
They apply to designated financial holding companies, banks, direct insurers, reinsurers and captive insurers incorporated in Singapore. Related requirements under MAS Notice 106 on director and key executive person appointments apply specifically to Direct Insurers (Life, General, and Composite), Reinsurers, and Captive Insurers, with the Notice 106 amendment taking effect 30 May 2026.
What is a Material Risk Taker under MAS's remuneration oversight expectations?
A Material Risk Taker (MRT) is an employee whose individual actions can have a material impact on the insurer's risk exposure, regardless of seniority. The Board Remuneration Committee is expected to actively oversee remuneration policy for this group and evaluate outcomes in aggregate to ensure they don't incentivise excessive risk-taking — not just review the pay of named executives.
Why do board minutes need to record unresolved concerns from independent directors?
MAS's Guidelines expect financial institutions to document unresolved concerns of independent directors in board minutes, particularly on matters related to how the company is run or proposed corporate actions. This creates a record of genuine board debate rather than only unanimous outcomes, and is often the first thing a regulator or post-incident review looks for as evidence of real governance versus rubber-stamping.
About the author
Raymond Cheung is a Chartered Actuary, C-suite executive and board adviser with more than 20 years of experience across Asia in risk management, insurance, ESG and corporate governance. He is the CEO of CER Consultancy and an accredited trainer at SMU Academy and the Singapore College of Insurance.